Handa Pharmaceuticals, Inc. (6620.TWO)
TWD 51.5
(-2.83%)
TWD 51.5
(-2.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.1 Billion | 197.67 Million | 29.23 Million | 28.85 Million | 84.07 Million |
| Cost of Revenue | 1.3 Million | 18.71 Million | 1.46 Million | 1.42 Million | 33.33 Million |
| Gross Profit | 1.1 Billion | 178.96 Million | 27.77 Million | 27.43 Million | 50.73 Million |
| Operating Expenses | 399.14 Million | 267.08 Million | 281.65 Million | 344.91 Million | 255.67 Million |
| Selling, General and Administrative Expenses | 104.87 Million | 87.3 Million | 72.66 Million | 70.87 Million | 66.77 Million |
| Research and Development Expenses | 306.72 Million | 179.77 Million | 208.98 Million | 274.04 Million | 188.9 Million |
| Other Expenses | - | 44.74 Million | -6.97 Million | 13.29 Million | - |
| Cost and Expenses | 412.89 Million | 285.79 Million | 283.11 Million | 346.33 Million | 289.01 Million |
| Operating Income | 695.79 Million | -42.86 Million | -260.56 Million | -315.49 Million | -204.94 Million |
| Interest Expense | 222 Thousand | 281 Thousand | 232 Thousand | 453 Thousand | 436 Thousand |
| Income Tax Expense | 65.6 Million | -3.13 Million | -13.13 Million | -38.34 Million | -25.36 Million |
| Earnings before Tax | 790.11 Million | -43.15 Million | -260.8 Million | -320.44 Million | -203.1 Million |
| Net Income | 726.88 Million | -40.01 Million | -247.67 Million | -282.1 Million | -177.73 Million |
| Earnings Per Share Basic | 5.41 | -0.32 | -2.07 | -2.37 | -1.58 |
| Earnings Per Share Diluted | 5.40 | -0.32 | -2.07 | -2.37 | -1.58 |
| Weighted Average Shares Outstanding | 134.3 Million | 125.56 Million | 119.58 Million | 118.78 Million | 112.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 134.72 Million | 125.56 Million | 119.58 Million | 118.78 Million | 112.75 Million |
| Gross Margin | 1.00 | 0.91 | 0.95 | 0.95 | 0.60 |
| EBIT Margin | 0.73 | -0.14 | -7.71 | -8.99 | -2.20 |
| Profit Margin | 0.66 | -0.20 | -8.47 | -9.78 | -2.11 |
| EBITDA | 802.78 Million | -27.68 Million | -225.4 Million | -264 Million | -184.68 Million |
| Earnings Before Tax Margin | 0.63 | -0.22 | -8.91 | -10.93 | -2.44 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 215.53 Million | 217.37 Million | 1.1 Billion | 300.03 Million | 240.02 Million | 235.02 Million |
| Cost of Revenue | 290 Thousand | 309 Thousand | 1.3 Million | 344 Thousand | 344 Thousand | 301 Thousand |
| Gross Profit | 215.24 Million | 217.06 Million | 1.1 Billion | 299.68 Million | 239.68 Million | 234.72 Million |
| Operating Expenses | 123.77 Million | 76.18 Million | 411.59 Million | 123.38 Million | 122.92 Million | 78.98 Million |
| Selling, General and Administrative Expenses | 31.19 Million | 28.13 Million | - | 38.29 Million | 22.97 Million | 8.53 Million |
| Research and Development Expenses | 92.57 Million | 48.05 Million | - | 85.08 Million | 99.94 Million | 70.45 Million |
| Other Expenses | -724 Thousand | 13.44 Million | 78.75 Million | -15.8 Million | 13.58 Million | 83.95 Million |
| Cost and Expenses | 124.06 Million | 76.49 Million | 412.89 Million | 123.72 Million | 123.26 Million | 79.28 Million |
| Operating Income | 109.58 Million | 166.9 Million | 792.7 Million | 171 Million | 139.86 Million | 240.19 Million |
| Interest Expense | 88 Thousand | 42 Thousand | 222 Thousand | 47 Thousand | 52 Thousand | 57 Thousand |
| Income Tax Expense | 7.12 Million | 49.76 Million | 65.6 Million | 84.12 Million | -6.21 Million | -7.04 Million |
| Earnings before Tax | 109.49 Million | 166.86 Million | 792.48 Million | 170.95 Million | 139.81 Million | 240.13 Million |
| Net Income | 102.37 Million | 117.09 Million | 726.88 Million | 86.82 Million | 146.02 Million | 247.18 Million |
| Earnings Per Share Basic | 0.73 | 0.83 | - | 0.63 | 1.07 | 1.85 |
| Earnings Per Share Diluted | 0.73 | 0.83 | - | 0.63 | 1.07 | 1.85 |
| Weighted Average Shares Outstanding | 140.59 Million | 140.59 Million | 134.3 Million | 137.45 Million | 136.47 Million | 133.33 Million |
| Weighted Average Shares Outstanding (Diluted) | 141.11 Million | 141.11 Million | 134.72 Million | 137.91 Million | 136.47 Million | 133.55 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 0.52 | 0.78 | - | 0.58 | 0.59 | 1.04 |
| Profit Margin | 0.47 | 0.54 | 0.66 | 0.29 | 0.61 | 1.05 |
| EBITDA | 112.08 Million | 169.14 Million | - | 173.67 Million | 142.66 Million | 243.51 Million |
| Earnings Before Tax Margin | 0.51 | 0.77 | 0.72 | 0.57 | 0.58 | 1.02 |
ETAOF
000150
LBL
FRST
MEVA
ARL